Its cardiotonic effect is equivalent to that of the digitalis western medicines (Digoxin)
It can reduce the myocardial apoptosis and autophagy
It has better effect in reducing renal aquaporin 2 than that of the western medicine Furosemide.
It can promote the proliferation of the myocardial cells.
It has better Angll inhibition effect than that of the western medicine Ramipril.
It can improve the energy metabolism of the cardiac muscles.
It has better effect in ventricular remodeling inhibition that that of the western medicine Metoprolol.
It can be used for the treatment of arrhythmia
A Model High-tech Industrialization Project of National Development and Reform Commission
An Innovative TCM Patent Drug for Chronic Heart Failure Resolving both Symptoms and Root Causes as Proved by Clinical Evidence Based Medicine
An Innovative TCM Patent Drug for Chronic Heart Failure with Excellent Therapeutic Effects Recognized by International Authoritative Journals
Recognized as a Recommended Innovative TCM Patent Drug by Heart Failure Diagnosis and Treatment Guide of Chinese Medical Association
Listed in the List of National Essential Drugs
A Product in the National Health Insurance Program
A High-tech Product of the Ministry of Science and Technology
A National Level Key New Product
A Project Funded by the National 863 Program of the Ministry of Science and Technology
A Backbone Science and Technology Project in the "Eleventh Five-year Plan"
Read this leaflet carefully, and take this medicine under the doctor or pharmacists’ direction
The product containing Prepared Common Monkshood Daughter Root
Generic name: Qili Qiangxin Capsules
ChinesePin yin: Qili Qiangxin Jiaonang
[Ingredients]Milkvetch Root,Ginseng, Prepared Common Monkshood Daughter Root,Danshen Root,Tansymustard Seed,Oriental Waterplantain Rhizome, Fragrant Solomonseal Rhizome, Cassia Twig,Safflower, Chinese Silkvine Root-bark, Dried Tangerine Peel
[Description] Capsules containing sepia to brown granules; taste bitter.
[Functions and Indications]Tonifyqi and warmYang,activate blood and unblock collaterals, induce diuresis to alleviate edema, it is used for mild and moderate congestive heart failure caused by coronary heart disease and hypertension, indicated by yang deficiency, blood blocking and liquid stagnation; withthe symptomsas flusteredness and short breath, more seriously when moving; unable to lie on back during sleep; legs edema; tireness and asthenia; less urine; mouth and lips hematocyanosis; chilly and cold in limbs, spit watery white phlegm.
[Administration and Dosage]For oral administration, 4 capsules once, 3 times daily.
[Precautions]Ifother heart failure drugs are used simultaneously, it is not recommended to stop the drug in a sudden.Please protect from moisture after opening the moisture proof bag.
[Pharmacology and Toxicology]Pharmacodynamic experiments show that: for experimental heart failure model of dog caused by pentobarbital and experimental chronic heart failuremodel of rabbit caused by aorta abdominalis ligation, this medicine could increase the myocardial contractility, cardiac output, kidney blood flow volume, decrease ventricle wall thickness, cardiac index, level of angiotensinⅡ and aldosterone, alleviate ventricle reconstruction. This medicine also could increase the amount ofmicturition in rat, and prolong life span of mouse under normal atmosphere, and extend mouse swimming time underlow temperature.
[Storage]Preserve in tightly closed containers.
[Package]Aluminium-plastic package,36 capsules/box
[Executive standard]Chinese Pharmacopoeia 2010, the 2nd supplemental volume
[Approval No.]GYZZ Z20040141
Company name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Manufacture address:No.238 Tianshan street, New and high development area, Shijiazhuang, Hebei, China.
Post code: 050035
Tel:800 8038581, +8631185901719, 400 8165108
Registration address:No.238 Tianshan street, New and high development area, Shijiazhuang, Hebei, China.
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD